Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
48,765,018
-
Share change
-
+898,996
-
Total reported value
-
$6,246,448,922
-
Put/Call ratio
-
75%
-
Price per share
-
$128.14
-
Number of holders
-
393
-
Value change
-
+$107,004,753
-
Number of buys
-
198
-
Number of sells
-
183
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q3 2019
As of 30 Sep 2019 Jazz Pharmaceuticals plc - SHS USD (JAZZ) had 393 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 48,765,018 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, Nuveen Asset Management, LLC, FMR LLC, LSV ASSET MANAGEMENT, STATE STREET CORP, Boston Partners, AQR CAPITAL MANAGEMENT LLC, and PUTNAM INVESTMENTS LLC.
This table shows 395 institutional shareholders of the security as of 30 Sep 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.